Ying Wu

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Top Venues

Science advances

Clinical cancer research : an official journal of the American Association for Cancer Research

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Bachchu Lal, Aditya Kulkarni, Joseph R McDermott, Rana Rais, Jesse Alt, Ying Wu, Hernando Lopez-Bertoni, Sophie Sall, Umesh Kathad, Jianli Zhou, Barbara S Slusher, Kishor Bhatia, John Laterra
Preclinical efficacy of LP-184, a tumor site activated synthetic lethal therapeutic, in glioblastoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Kathryn M Lemberg, Eunus S Ali, Marcela Krecmerova, Joanna Marie H Aguilar, Jesse Alt, Diane E Peters, Liang Zhao, Ying Wu, Naziba Nuha, John M Asara, Verena Staedtke, Christine A Pratilas, Pavel Majer, Rana Rais, Issam Ben-Sahra, Barbara S Slusher
Pro-905, a novel purine antimetabolite, combines with glutamine amidotransferase inhibition to suppress growth of malignant peripheral nerve sheath tumor. Molecular cancer therapeutics (2023)
Rana Rais, Kathryn M Lemberg, Lukáš Tenora, Matthew L Arwood, Arindom Pal, Jesse Alt, Ying Wu, Jenny Lam, Joanna Marie H Aguilar, Liang Zhao, Diane E Peters, Carolyn Tallon, Rajeev Pandey, Ajit G Thomas, Ranjeet P Dash, Tanguy Y Seiwert, Pavel Majer, Robert D Leone, Jonathan D Powell, Barbara S Slusher
Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug. Science advances 8 (46) (2022)